Clinical Trials Directory

Trials / Conditions / Clostridioides Difficile Infection Recurrence

Clostridioides Difficile Infection Recurrence

8 registered clinical trials studyying Clostridioides Difficile Infection Recurrence — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingFMT Capsules for rCDI
NCT07458984
Helsinki University Central HospitalPhase 3
RecruitingC. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment fo
NCT07250724
Bactolife A/S—
Not Yet RecruitingSTOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing
NCT07120490
Medical University of WarsawN/A
RecruitingSecondary Prevention of Clostridioides Difficile Using Vancomycin
NCT06979609
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 2 / Phase 3
RecruitingVE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452
Vedanta Biosciences, Inc.Phase 3
RecruitingChanges in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825
Fondazione Policlinico Universitario Agostino Gemelli IRCCS—
CompletedBezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection
NCT05304715
Hellenic Institute for the Study of SepsisPhase 2
CompletedPhase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT03788434
Vedanta Biosciences, Inc.Phase 2